MAPT and early-onset autosomal dominant Alzheimer disease: Phosphorylation of different tau sites (Tyr18, Ser199, Ser202/Thr205, Thr231, Ser262, Ser396 and Ser422) could be used to measure the progression of Alzheimer’s disease [26], at the determinate by looking at postmortem issues.